Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study (Q44912433)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study |
scientific article |
Statements
1 reference
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study (English)
1 reference
1 reference
1 reference
1 reference
1 reference
Gianantonio Rosti
1 reference
Fausto Castagnetti
1 reference
Giuliana Alimena
1 reference
Giovanni Martinelli
1 reference
Michele Baccarani
1 reference
Fabrizio Pane
1 reference
Giovanna Rege-Cambrin
1 reference
Luciano Levato
1 reference
Kimmo Porkka
1 reference
Henrik Hjorth-Hansen
1 reference
Veli Kairisto
1 reference
Arnon Nagler
1 reference
Johan Lanng Nielsen
1 reference
Ugur Ozbek
1 reference
Fausto Palmieri
1 reference
Domenico Russo
1 reference
Ole Weiss-Bjerrum
1 reference
Bengt Simonsson
1 reference
4 March 2009
1 reference
Identifiers
1 reference